Related Experiment Video
Updated: Jul 13, 2026
07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
The feto-maternal interface: setting the stage for potential immune interactions.
1Institute of Cell Biology, Histology, and Embryology, Medical University of Graz, Harrachgasse 21/7, 8010, Graz, Austria. berthold.huppertz@meduni-graz.at
Seminars in Immunopathology
|July 12, 2007
Summary
This study explores the morphological sites where fetal and maternal tissues interact during human implantation and placentation. Understanding these interactions is crucial for maintaining pregnancy and preventing immune rejection of the conceptus.
Area of Science:
- Reproductive biology
- Immunology
- Developmental biology
Background:
- Human implantation and placentation involve critical interactions between fetal and maternal tissues.
- Maintaining pregnancy requires a complex interplay of maternal and fetal factors.
- Immunological interactions are vital at various stages, including blastocyst attachment and trophoblast invasion.
Purpose of the Study:
- To introduce the morphological sites of interaction between fetal and maternal tissues during human implantation and placentation.
- To provide a foundation for immunologists to develop hypotheses regarding immune interactions during pregnancy.
- To enhance understanding of the mechanisms preventing the rejection of the conceptus.
Main Methods:
- Morphological analysis of fetal-maternal interaction sites.
- Review of existing literature on implantation and placentation immunology.
- Integration of developmental and immunological perspectives.
Main Results:
- Detailed description of key morphological sites of fetal-maternal contact.
- Identification of specific locations where immune modulation is likely to occur.
- Visual representation of interaction zones relevant to immunological studies.
Conclusions:
- Morphological insights into implantation sites are essential for understanding pregnancy immunology.
- This study provides a framework for investigating the immunobiology of pregnancy.
- Further research into these sites can elucidate mechanisms of immune tolerance during gestation.
Related Concept Videos
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:15Transcytosis of IgG
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...